Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Truist Financial Co. from $50.00 to $63.00. They now have a "hold" rating on the stock.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Stockholders to Learn More About the Investigation
Inari Medical, Inc. (NASDAQ: NARI) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $75.00 price target on the stock.
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Investors to Inquire about Securities Investigation
NARI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Inari Medical, Inc. and Encourages Investors to Contact the Firm